| Ms Kathleen Ellen Grzybowski, RN | |
|
11212 Highway 151, San Antonio, TX 78251-4498 | |
| (405) 708-8049 | |
| Not Available |
| Full Name | Ms Kathleen Ellen Grzybowski |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 11212 Highway 151, San Antonio, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013667716 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 955805 (Texas) | Secondary |
| 163W00000X | Registered Nurse | 955805 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kathleen Ellen Grzybowski, RN 14431 Palomino Pl, San Antonio, TX 78254-4416 Ph: (405) 708-8049 | Ms Kathleen Ellen Grzybowski, RN 11212 Highway 151, San Antonio, TX 78251-4498 Ph: (405) 708-8049 |
News Archive
A team of Massachusetts General Hospital investigators has developed a device with the potential of shortening the time required to rapidly diagnose pathogens responsible for health-care-associated infections from a couple of days to a matter of hours.
Air pollution significantly increases the risk for premature deaths, particularly in people with underlying cardiovascular disease, clinical and epidemiological studies have determined.
The goal of this research was to create an ECM modified hyaluronic acid (HA) based hydrogel culture system that allows for the growth and differentiation of salivary acinar cells into functional acini-like structures capable of secreting large amounts of protein and fluid unidirectionally. Xerostomia, a condition resulting from irradiation of the head and neck, affects more than 40,000 cancer patients each year in the United States. According to this research, these patients will greatly benefit from the development of a functional implantable artificial salivary gland.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
› Verified 2 days ago
Jessica M. Stephens, PNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4507 Medical Dr, San Antonio, TX 78229 Phone: 210-692-0234 | |
Michael Brand, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 722 W Craig Pl, San Antonio, TX 78212 Phone: 210-682-9881 Fax: 210-682-9882 | |
Marie Laurette Farah Francoeur, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7330 San Pedro Ave Ste 800, San Antonio, TX 78216 Phone: 210-737-8090 | |
Belinda Segura, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8318 Jones Maltsberger Rd Ste 121, San Antonio, TX 78216 Phone: 210-348-7529 | |
Justine M Hernandez, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8438 Angelina Parke, San Antonio, TX 78254 Phone: 210-833-0068 | |
Donna Taylor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Babcock Rd Ste 304, San Antonio, TX 78229 Phone: 210-731-9570 | |
Marles Sylvia Copeland, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4334 N Loop 1604 W, San Antonio, TX 78249 Phone: 210-918-8737 |